4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-062078
Chief Operating Officer sold 2,738 shares at an average $28.27 ($77,402)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HIGH SUSANNA GATTI Chief Operating Officer | 2024-05-16 | Sale 10b5-1 | −2,249 | $28.20 | $63,422 | 154,551 | D |
| HIGH SUSANNA GATTI Chief Operating Officer | 2024-05-16 | Sale 10b5-1 | −489 | $28.59 | $13,981 | 154,062 | D |
| Open-market sales · 2,738 sh · avg $28.27 · $77,402 | |||||||
Loading xslF345X05/ownership.xml…